SR ONE CAPITAL MANAGEMENT, LP logo

SR ONE CAPITAL MANAGEMENT, LP Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for SR ONE CAPITAL MANAGEMENT, LP with $691.4M in long positions as of Q3 2025, 82% allocated to Healthcare, and 98% concentrated in top 10 positions.

Portfolio Value
$691.4M
Top 10 Concentration
98%
Top Sector
Healthcare (82%)
US Exposure
79%
Market Cap Focus
Mid Cap
Countries
3

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 81.90%Healthcare
Healthcare
81.90%

Industry Breakdown

1 industry across all sectors

Biotechnology: 81.90%Biotechnology
Biotechnology
Healthcare
81.90%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 58.57%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 24.66%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 1.00%Nano Cap (< $50M): 15.77%Nano Cap (< $50M)
Mid Cap ($2B - $10B)
58.57%
Small Cap ($300M - $2B)
24.66%
Micro Cap ($50M - $300M)
1.00%
Nano Cap (< $50M)
15.77%

Portfolio Concentration

Top 10 Holdings %
98.44%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
79.33%
International
20.67%
Countries
3
Largest Int'l Market
Switzerland - 19.93%
United States of America
79.33% ($548.5M)
9 holdings
Switzerland
19.93% ($137.8M)
2 holdings
Canada
0.74% ($5.1M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
8.3 quarters
Avg. Top 20
7.5 quarters
Avg. All Positions
7.5 quarters
Median Holding Period
5.5 quarters
Persistence Rate
83.33%
Persistent Holdings Weight
91.34%
Persistent Positions
10
Longest Held
Design Therapeutics, Inc. Common Stock logo
Design Therapeutics, Inc. Common StockDSGN - 15 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.000%
Avg. Position Weight
8.33%
Largest Position
Arcellx, Inc. Common Stock logo
Arcellx, Inc. Common StockACLX - 27.86%
Largest Ownership Stake
Design Therapeutics, Inc. Common Stock logo
Design Therapeutics, Inc. Common StockDSGN - 11.46%
Avg. Ownership Stake
3.43%
Ownership Stake >5%
1
Ownership Stake >1%
9

Historical (Since Q4 2021)

Avg. New Position
16.82%
Avg. Ownership Stake
6.28%
Largest Position
Design Therapeutics, Inc. Common Stock logo
Design Therapeutics, Inc. Common StockDSGN - 100.00% (Q4 2021)
Largest Ownership Stake
EFTR
EFFECTOR THERAPUTCS INCEFTR - 16.28% (Q4 2022)

Portfolio Turnover

Current Quarter

Turnover Ratio
7.6%
Value Traded
$52.73M
Positions Added
0
Positions Exited
1

Historical (Since Q4 2021)

Avg. Turnover Ratio
10.2%
Avg. Positions Added
1
Avg. Positions Exited
0
Highest Turnover
50.0%
Q4 2021

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.